Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Organon & Co. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 1 | 995 | +994 |
| Shares | 3.40K | 174.3M | +174.3M (+5,125,593.3%) |
| Value | $103.0K | $5.27B | +$5.27B (+5,117,642.9%) |
New holders (994)
Institutions that held Organon & Co. at the end of Q2 2021 but not at the end of Q1 2021.
Showing the largest 100 of 994 by value.
Sold out (0)
Institutions that held Organon & Co. at the end of Q1 2021 and filed for Q2 2021 without it.
None.